Special Issue "Innovation of Analysis Methods in Pharmaceutical Chemistry"

A special issue of Separations (ISSN 2297-8739).

Deadline for manuscript submissions: 30 September 2021.

Special Issue Editor

Dr. Giorgio Marrubini
E-Mail Website
Guest Editor
Department of Drug Sciences, University of Pavia, Pavia, Italy
Interests: analytical chemistry; pharmaceutical analysis; analytical toxicology; method validation; robustness testing; chromatographic techniques; data analysis; design of experiments (DoE)
Special Issues and Collections in MDPI journals

Special Issue Information

Dear Colleagues,

Compendial and other official chromatographic methods often give the impression of being awkward and/or old-fashioned. This is mainly because chromatography base materials, and the chemical modifications thereof as well as the instruments, have been continuously improved over the years, but where the methods have not kept up with speed and performance. In pharmaceutical analysis, this subject is of particular relevance. It is a general feeling that there is the need to modernize many of the existing monographs both in terms of the materials that can be used and to find alternative separation mode solutions. HPLC columns of traditional format (250x4.6 mm, packed with particles of 10 or 5 microns diameter) are obsolete and could be successfully replaced by greener and more efficient columns having smaller formats. Also, modern materials for stationary phases do not suffer any more of the problems of the past, such as metals contamination and free silanols secondary interactions. Therefore, a change in the composition of the mobile phase may also be necessary when it comes to the time to change the old column used for a compendial method.

Ion-chromatography and Hydrophilic Interaction Liquid Chromatography (HILIC) have been shown as valuable complements to reversed-phase LC and are today viable and robust options together with normal-phase LC.

As strong evidence of this trend, the United States Pharmacopoeia (USP), for about ten years, started a global initiative to modernize existing monographs actively seeking industry collaborators to assist in the development of new monographs. Also, the scientific community is expecting soon the release of the final document of ICH Q14 “Analytical Procedure Development and Revision of Q2(R1) Analytical Validation” guideline that should list new requirements for validation of measurement methods.

This Special Issue aims to present readers with the latest research regarding method scaling, alternative separation mode solutions, and innovative approaches to tackle pharmaceutical analysis. The issue invites contributions relating, but not limited to, innovation in chromatographic pharmaceutical analysis, method development, and multivariate tools for data treatment.

Dr. Giorgio Marrubini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Separations is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • phamaceutical analysis
  • USP alternative methods
  • method scaling
  • method adaptations
  • ion chromatography
  • HILIC
  • multivariate approaches
  • design of Experiments
  • quality by Design
  • changes in compendial methods

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
Developing a Fast Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for High-Throughput Surface Contamination Monitoring of 26 Antineoplastic Drugs
Separations 2021, 8(9), 150; https://doi.org/10.3390/separations8090150 (registering DOI) - 10 Sep 2021
Abstract
Growing attention on carcinogenicity and mutagenicity of antineoplastic drugs (ADs) from the International Agencies has led to the present strict safe handling and administration regulations. Accordingly, one of the most common ways to assess occupational exposure to these substances is to identify and [...] Read more.
Growing attention on carcinogenicity and mutagenicity of antineoplastic drugs (ADs) from the International Agencies has led to the present strict safe handling and administration regulations. Accordingly, one of the most common ways to assess occupational exposure to these substances is to identify and quantify possible surface contamination inside hospital preparation and administration units. Thus, it is essential to develop a fast and high-throughput monitoring method capable of identifying a significant number of ADs. The present study reports developing a UHPLC–MS/MS analysis to screen 26 ADs surface contamination through wipe test sampling. A Cortecs UPLC T3 50 × 2.1 mm (1.6 µm) column was selected to perform the analysis, using the evaluations of previous studies and the Product Quality Research Institute (PQRI) database. The design of experiments (DoE) methodological approach was used to optimize the chromatographic conditions concerning the best separation between all ADs. The limits of quantification for the analytes were between the pg/mL and ng/mL orders, and the turnaround time was limited to about 15 min. The obtained accuracy was mostly between 90% and 110% for all the analytes, while the precision was under 10% and a low matrix effect was observed for said analytes. Only vindesine and docetaxel presented lower performances. Full article
(This article belongs to the Special Issue Innovation of Analysis Methods in Pharmaceutical Chemistry)
Show Figures

Figure 1

Article
Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors
Separations 2021, 8(7), 92; https://doi.org/10.3390/separations8070092 - 28 Jun 2021
Viewed by 399
Abstract
Background/Aim: A number of biologically active substances were proved as an alternative to conventional anticancer medicines. The aim of the study is in vitro investigation of the anticancer activity of mono- and di-Rhamnolipids (RL-1 and RL-2) against human breast cancer. Additionally, the combination [...] Read more.
Background/Aim: A number of biologically active substances were proved as an alternative to conventional anticancer medicines. The aim of the study is in vitro investigation of the anticancer activity of mono- and di-Rhamnolipids (RL-1 and RL-2) against human breast cancer. Additionally, the combination with Cisplatin was analyzed. Materials and Methods: Breast cell lines (MCF-10A, MCF-7 and MDA-MB-231) were treated with RLs and in combination with Cisplatin. The viability was analyzed using MTT assay, and investigation of autophagy was performed via acridine orange staining. Results: In contrast to the healthy cells, both tested cancer lines exhibited sensitivity to RLs treatment. This effect was accompanied by an influence on the autophagy-related acidic formation process. Only for the triple-negative breast cancer cell line (MDA-MB-231) the synergistic effect of the combined treatment (10 µM Cisplatin and 1 µg/mL RL-2) was observed. Conclusion: Based on studies on the reorganization of membrane models in the presence of RL and the data about a higher amount of lipid rafts in cancer cell membranes than in non-tumorigenic, we suggest a possible mechanism of membrane remodelling by formation of endosomes. Shortly, in order to have a synergistic effect, it is necessary to have Cisplatin andRL-2 as RL2 is a molecule inducingpositive membrane curvature. Full article
(This article belongs to the Special Issue Innovation of Analysis Methods in Pharmaceutical Chemistry)
Show Figures

Figure 1

Article
Characterization and Separation of Platinum-Based Antineoplastic Drugs by Zwitterionic Hydrophilic Interaction Liquid Chromatography (HILIC)–Tandem Mass Spectrometry, and Its Application in Surface Wipe Sampling
Separations 2021, 8(5), 69; https://doi.org/10.3390/separations8050069 - 20 May 2021
Viewed by 649
Abstract
Platinum-based antineoplastic drugs (PtADs) are among the most important and used families of chemotherapy drugs, which, even showing severe side effects and being hindered by drug resistance, are not likely to be replaced clinically any time soon. The growing interest in the occupational [...] Read more.
Platinum-based antineoplastic drugs (PtADs) are among the most important and used families of chemotherapy drugs, which, even showing severe side effects and being hindered by drug resistance, are not likely to be replaced clinically any time soon. The growing interest in the occupational health community in antineoplastic drug (AD) surface contamination requires the development of increasingly fast and easy high-throughput monitoring methods, even considering the lack of harmonized legally binding regulation criteria. Thus, a wipe sampling method together with zwitterionic hydrophilic interaction liquid chromatography (HILIC-Z)–tandem mass spectrometry (MS/MS) analysis was developed for the simultaneous evaluation of oxaliplatin, cisplatin, and carboplatin surface contaminations. A design of experiments approach was used to optimize the chromatographic conditions. Limits of quantification ranging from 2 to 5 ng/mL were obtained from interday and intraday repetitions for oxaliplatin and carboplatin, and between 170 and 240 ng/mL for cisplatin. The wipe desorption procedure is equivalent to other AD sampling methods, enabling a fast sample preparation, with an LC-MS/MS analysis time of less than 7 min. Full article
(This article belongs to the Special Issue Innovation of Analysis Methods in Pharmaceutical Chemistry)
Show Figures

Graphical abstract

Back to TopTop